There is no Press for this Ticker
Sector: Health Care.Industry: Biotechnology
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Related Companies

TickerCompanyChg %Mkt Cap
INNMFAmplia Therapeutics0%20.6M

Amplia Therapeutics Company Questions & Answers

Q

How do I buy Amplia Therapeutics (INNMF) stock?

A

You can purchase shares of Amplia Therapeutics (OTC: INNMF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Amplia Therapeutics's (INNMF) main competitors?

A

There are no as such competitors for Amplia Therapeutics.

Q

What is the target price for Amplia Therapeutics?

A

There is no analysis for Amplia Therapeutics

Q

How much is Amplia Therapeutics (INNMF) stock ?

A

The stock price for Amplia Therapeutics (OTC: INNMF) is $0.191 last updated Thu Apr 15 2021 15:49:20 GMT+0000 (Coordinated Universal Time).

Q

When is the next Amplia Therapeutics (INNMF) dividend?

A

There are no upcoming dividends for Amplia Therapeutics.

Q

When is Amplia Therapeutics (OTC:INNMF) reporting earnings?

A

There are no earnings for Amplia Therapeutics

Q

When is the upcoming split for INNMF?

A

There is no upcoming split for Amplia Therapeutics.